Create Account Sign In
COVID-19 Vaccination for patients under the cancer therapy
ESGO eAcademy. Haanen, Mansoor Raza Mirza, Zoia Razumova, Anna Fagotti, Elzbieta van der Steen Banasik & Ico Toth J. 03/20/21; 318267
John Haanen, Mansoor Raza Mirza, Zoia Razumova, Anna Fagotti, Elzbieta van der Steen Banasik & Ico Toth
John Haanen, Mansoor Raza Mirza, Zoia Razumova, Anna Fagotti, Elzbieta van der Steen Banasik & Ico Toth
Login now to access Regular content available to all registered users.
Click here to create a free account.

Access to Premium content is currently a membership benefit.

Click here to join ESGO or renew your membership.

You may also access ESGO content "anytime, anywhere" with the FREE ESGO eAcademy App for iOS and Android.
About this activity
Discussion Forum (0)
Rate & Comment (0)
Cancer patients are recommended to be vaccinated against COVID19, however there are multiple unanswered questions among medical professionals: Which vaccine? When is best to be vaccinated? Are there any increased adverse effects? Does vaccination negatively impact the efficacy of cancer therapy? ...

It is our pleasure to have Prof John Haanen, the leading expert to discuss all above with our ESGO colleagues.



Moderator: Mansoor Raza Mirza, Denmark

Co-moderator: Zoia Razumova, Sweden



Main Speaker: John Haanen, The Netherlands

Division of Molecular Oncology & Immunology, 

Netherlands Cancer Institute (NKI) in Amsterdam



Panellists:

Anna Fagotti, Italy, gynaecological oncologist

Elzbieta van der Steen Banasik, The Netherlands, radiation oncologist

Ico Toth, Hungary, ENGAGe chair - patient advocacy representative

 
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies